Skip to main content

Atezolizumab A1698

Information leaflet on Atezolizumab

 

This leaflet provides information for patients having treatment with Atezolizumab.   The leaflet will explain what Atezolizumab is and when and how it is given.  It will also tell you about common side effects that you may experience.  Contact telephone numbers and details of how to obtain further information on Atezolizumab are given at the end of the leaflet.

 

What is Atezolizumab and why am I having it?

Atezolizumab is a treatment which helps your immune system to attack and destroy cancer cells. Atezolizumab is used to treat your type of cancer, but it is not a chemotherapy drug, it is immunotherapy.

 

How often will I receive Atezolizumab?

For this treatment to be most effective, it is given at specific time intervals.  It is usual to have Atezolizumab every 3 or 4 weeks.  Your doctor will discuss how often you will receive your treatment  with you and how long you will have to continue having the treatment.

 

How often will I see the specialist team?

You will need to be reviewed a few days before your treatment.  This will either be face to face in an outpatient clinic or a telephone consultation.  At each outpatient clinic or over the telephone the medical team who prescribes your Atezolizumab will check how you are feeling and discuss any problems you may have.

 

You will also have regular blood tests This is so we can check how the treatment is affecting you.  If your blood results are satisfactory, your treatment will be given.

 

How is Atezolizumab given?

Atezolizumab is given by subcutaneous injection under the skin on your thigh.  The administration of Atezolizumab by subcutaneous injection will take approx. 7 minutes.  The injection site will change from your left to right thigh each treatment cycle.  In order for the Nurse to give the injection into your leg it is advisable to wear comfortable loose-fitting clothing, for example a skirt or trousers, to enable access to your thigh for administration on the day of your treatment.

 

Where will my treatment be given?

The treatments will be given in the day case treatment areas at Velindre or in one of the Velindre Cancer Centre outreach clinics

 

How long will I be in the hospital?

Your first treatment will take approximately 30 minutes but please allow 1 hour on the unit.

 

Can I bring relatives and friends with me?

 

You are welcome to bring someone to stay with you during your treatment. Space is limited so there is not usually room for more than one person.  Treatment areas are not suitable for young children.

 

 

Reactions during the treatment

If you experience any of the following during the treatment please tell your nurse straight away:

 

  • Feeling hot and feverish
  • Chills or shivering
  • Headache
  • Dizziness or faintness
  • Problems with breathing or wheeze.
  • Rash or itching
  • Feeling sick or vomiting
  • Facial swelling

 

If any of these occur we may need to give you medication to help to settle the sensitivity reaction.

 

What are the possible side effects?

Some people have very few side effects whilst others may experience more. 

You may have injection site reactions. It is usually mild and around the injection site there may be pain, red skin or rash.

Most of the side effects happen because Atezolizumab affects the immune system causing inflammation of other parts of the body such as the skin, the bowels and hormone producing glands. Most, if not all severe side effects can be controlled by the use of steroid medication immediately either as tablets or through a drip.  Hospital admission may become necessary, however, for severe immune related reactions.

 

Mostly side effects are mild and can be easily managed at home. But it is important that if you have more severe side effects that you contact Velindre Cancer Centre. The telephone number is at the end of the leaflet.  Further details of when to contact Velindre are included in the individual side effects listed below.

 

If you are admitted to another hospital, you must inform the doctors and the nurses that you are taking Atezolizumab.  It is possible you could be having an immune reaction and should be started on steroids. The doctors and nurses need to contact Velindre Cancer Centre for advice.  They can either telephone the chemotherapy pager or speak to your oncologist.

 

You will be given an alert card, please show this to the nurses or doctors if you are admitted to any hospital.

 

Flu-like symptoms/Chills

 

You may experience flu-like symptoms and chills. However, if you have signs of infection, such as cough, cold, passing urine more frequently or stinging or coughing up green phlegm, ring Velindre cancer centre on the telephone at the end of the leaflet.

 

Nausea and vomiting

 

Atezolizumab can cause nausea and vomiting If you experience nausea, we can give you anti sickness medication to help. If the anti sickness medication does not help or you vomit, contact Velindre Cancer Centre for advice.  The telephone number is at the end of the leaflet.

 

Effects on the bowels  

 

This treatment has been known to cause diarrhoea. 

If you experience diarrhoea it is important that you drink plenty of fluids.  Medication is available to control diarrhoea.  If you have 4 or more bowel movements in 24 hours above what is normal for you please contact Velindre Cancer Centre immediately.  The telephone number is at the end of the leaflet.

Please note:

If you have any of the symptoms below you must inform Velindre Cancer Centre immediately, the telephone numbers are at the end of the leaflet.

 

  • 4 or more bowel movements in 24 hours above what is normal for you.
  • if you have any problems with diarrhoea or an increase in bowel movements which lasts for more than 3 days.
  • If you have severe stomach pains
  • Or if you have blood or mucus in your bowel motions

 

There is a risk of inflammation of the bowel (colitis) or rupture of the bowel (perforation) in a small minority of patients. Therefore it is important to inform us of any of the above symptoms or abdominal pain or swelling.

 

Effects on the skin

 

You may develop an itching skin rash which can be treated with moisturising cream.  However if you get a severe skin reaction you may need to be treated in hospital.

 

Please contact Velindre Cancer Centre if:

 

  • If the rash covers more than half of your body and is painful.
  • If you have large blisters or your skin is peeling.
  • If your skin feels very raw.
  • If you have itchy eyes.
  • If you have mouth ulcers. 

 

Effects on your hormone glands

 

Atezolizumab can cause inflammation of the glands that produce the different hormones (chemicals that control many of the body’s functions) in the body. Symptoms will vary depending on which glands are affected.

 

It is important to contact Velindre cancer Centre if you have the following :

  •  a headache that will not go away
  •  nausea and vomiting
  •  severe mood swings.
  •  severe tiredness (mild to moderate tiredness is  common with Atezolizumab)
  • If you have a noticeable increase in energy levels or restlessness.
  • If you feel forgetful and/or confused

 

Tiredness and fatigue

 

Atezolizumab can make you feel more tired than usual.  It is important to listen to your body and rest if you need to, but carry out your normal activities if you feel able.  Some people find it beneficial to take gentle exercise as well as taking rest.  If you are sleeping more than 50% during the daytime you need to contact Velindre Cancer Centre on the number at the end of the leaflet

 

Loss of appetite

 

You may experience a loss of appetite and some people may feel sick whilst taking Atezolizumab but this can usually be well controlled with anti sickness medication.  If you are sick more than once in 24 hours despite taking regular anti-sickness medicine, you should contact Velindre Cancer Centre for advice.  The telephone number is at the end of the leaflet.

 

Myalgia (pain in the muscles)

Some patients may experience myalgia which is muscle or joint pain.   If you already have painkillers at home you may find they relieve the pain.  If this does not work please contact Velindre Cancer Centre.  The telephone number is at the end of the leaflet. 

 

Risk of bleeding

Atezolizumab may reduce the production of platelets (which help the blood to clot).  This will increase your risk of bruising or bleeding.  If you notice any excessive bruising on your body or bleeding such as nosebleeds or bleeding from your gums you should contact Velindre Cancer Centre for advice.  The telephone number is at the end of the leaflet.

 

Effects on breathing:

 

If you experience shortness of breath, cough or any breathing difficulties it is important to inform the treatment helpline in Velindre cancer centre, on the telephone at the end of the leaflet. It is possible to develop a condition called pneumonitis, which can be life-threatening and needs to be treated .

 

 

Effects on the liver

 

This is rare, but if you are affected you may feel more tired than usual and may also feel sick or vomit.  Your doctor will give you anti sickness medicine to take. 

 

Please contact Velindre Cancer Centre if:

 

  • If you vomit more than once in 24 hours despite taking anti sickness medication.

 

More severe effects on the liver are very rare but can be very serious so you should contact Velindre Cancer Centre if:

 

  • If you have yellowing of your skin and the whites of your eyes.
  • If you have darker urine than normal.
  • If you have unusual bruising or bleeding

 

Other side effects:

You may have these additional side effects, if so please contact Velindre Cancer Centre:

 

  • Increased frequency of passing urine and/or thirst.
  • Dizziness or light headedness.
  • Decreased urine output.
  • Blurred or altered vision or red sore eyes.
  • Low blood pressure
  • Altered sensation to hands/feet or other areas of the body.

 

 

 

Other information

It is important you do not become pregnant, breastfeed or father a child whilst having Atezolizumab treatment and for a year after treatment.

It is recommended not to have live vaccines whilst on Atezolizumab.

Inform your oncologist if you have any autoimmune diseases for example: Crohns , Ulcerative colitis, Lupus, Multiple sclerosis.

Inform your oncologist if you are on long term steroids.

 

Side effects may continue for up to 6 months after treatment.  If you have any side effects contact your consultant. If you are admitted to hospital or see your GP during this period, inform the doctor you have had Atezolizumab, an immunotherapy medication, and show them your alert card.

 

Sometimes cancer drugs can have very serious side effects which can be life threatening. It is important to inform Velindre cancer centre if you are concerned about any side-effects.

 

A diagnosis of cancer can increase your risk of developing a blood clot (thrombosis), and having cancer treatment may increase this risk further.  It is important to tell your doctor immediately if you have symptoms such as pain, redness and swelling in your leg, or breathlessness and chest pain. 

 

Blood clots can be very serious.  However, most clots can usually be successfully treated with drugs to thin the blood.  Your doctor or nurse can give you more information.

 

Manufacturer’s patient information leaflets

Velindre leaflets provide information about very common and common side-effects: for more information regarding the less common side-effects please refer to the manufacturers patient information leaflets, obtained from Velindre pharmacy and/or on the internet at www.medicines.org.uk. Sometimes patients may find these leaflets difficult to read however. Please ask if you would like a copy from your doctor or from

 

Contact telephone numbers

 

Velindre Cancer Centre          029 2061 5888

If you are unwell at home and need immediate attention at any time of the day or night ask for the treatment helpline

 

 

Pharmacy department            029 2061 5888 ext 6223

Monday – Friday 9am – 5pm for queries about your medicines

 

Tenovus freephone                0808 808 1010

cancer helpline

This leaflet was written by health professionals.  The information contained in this leaflet is evidence based.  The leaflet has been approved by doctors, nurses, pharmacists and patients.  It is reviewed and updated every 2 years.

 

Prepared November 2017

Updated November 2023